E-pharmacies in India have seen a 25-65 percent jump in their sales, mostly of common drugs, health supplements, medical devices, and personal protective equipment (PPE). A soaring number of infections during the second coronavirus wave in the country, coupled with local lockdowns, have made people turn to online health resources instead of usual visits to offline pharmacies and diagnostic centers, ET has reported.

1mg said sales of Doxzee and Fabiflu, both used in the treatment of COVID-19, have jumped 40-50 times in April compared to March. The demand for COVID-19 related products increased five times in April from March, it said. Sales would be much higher if product supplies were available.